These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin. Walter M; Plotnick M; Schechter NM Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699 [TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor. Ying QL; Kemme M; Saunders D; Simon SR Am J Physiol; 1997 Mar; 272(3 Pt 1):L533-41. PubMed ID: 9124611 [TBL] [Abstract][Full Text] [Related]
7. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Rao NV; Marshall BC; Gray BH; Hoidal JR Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Wright CD; Kennedy JA; Zitnik RJ; Kashem MA Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546 [TBL] [Abstract][Full Text] [Related]
11. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241 [TBL] [Abstract][Full Text] [Related]
12. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function. Yang J; Zhu J; Sun D; Ding A Biochim Biophys Acta; 2005 Sep; 1745(3):310-7. PubMed ID: 16112212 [TBL] [Abstract][Full Text] [Related]
14. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Bergenfeldt M; Axelsson L; Ohlsson K Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620 [TBL] [Abstract][Full Text] [Related]
15. Interaction of heparin with rat mast cell protease 1. Pejler G; Maccarana M J Biol Chem; 1994 May; 269(20):14451-6. PubMed ID: 8182050 [TBL] [Abstract][Full Text] [Related]
16. Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa. Bergenfeldt M; Nyström M; Bohe M; Lindström C; Polling A; Ohlsson K J Gastroenterol; 1996 Feb; 31(1):18-23. PubMed ID: 8808424 [TBL] [Abstract][Full Text] [Related]
17. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. King AE; Critchley HO; Kelly RW Mol Hum Reprod; 2000 Feb; 6(2):191-6. PubMed ID: 10655462 [TBL] [Abstract][Full Text] [Related]
18. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. Ohlsson K; Bjartell A; Lilja H J Androl; 1995; 16(1):64-74. PubMed ID: 7539415 [TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391 [TBL] [Abstract][Full Text] [Related]
20. The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man. Nyström M; Bergenfeldt M; Ohlsson K Scand J Clin Lab Invest; 1997 Apr; 57(2):119-25. PubMed ID: 9200270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]